Norethisterone acetate in the treatment of scleroderma.
Barnett
A J
AJ
Marks
R
R
D000328:Adult; D000368:Aged; D001695:Biology; D001777:Blood Coagulation; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D004194:Disease; D004617:Embolism; D005069:Evaluation Studies as Topic; D005193:Family Planning Services; D005260:Female; D006801:Humans; D006973:Hypertension; D008875:Middle Aged; D009640:Norethindrone / Q000627:therapeutic use*; D010827:Physiology; D012106:Research; D012595:Scleroderma, Systemic / Q000188:drug therapy*; D012867:Skin; D013923:Thromboembolism; D013927:Thrombosis; D014652:Vascular Diseases
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D009640:Norethindrone
Biology; Blood Coagulation Effects; Clinical Research; Contraception; Contraceptive Agents, Female--therapeutic use; Contraceptive Agents, Progestin--therapeutic use; Contraceptive Agents--therapeutic use; Dermatological Effects; Diseases; Embolism; Evaluation; Family Planning; Hypertension; Norethindrone Acetate--therapeutic use; Norethindrone--therapeutic use; Oral Contraceptives; Physiology; Research Methodology; Thromboembolism; Thrombosis; Vascular Diseases